TELCON RF PHARMACEUTICAL. Inc. (200230.KQ)

KRW 598.0

(0.0%)

EBITDA Summary of TELCON RF PHARMACEUTICAL. Inc.

  • TELCON RF PHARMACEUTICAL. Inc.'s latest annual EBITDA in 2023 was 5.2 Billion KRW , up 2284.56% from previous year.
  • TELCON RF PHARMACEUTICAL. Inc.'s latest quarterly EBITDA in 2024 Q2 was 63.86 Million KRW , up 101.03% from previous quarter.
  • TELCON RF PHARMACEUTICAL. Inc. reported an annual EBITDA of -36.77 Billion KRW in 2022, up 160.17% from previous year.
  • TELCON RF PHARMACEUTICAL. Inc. reported an annual EBITDA of -363.07 Million KRW in 2021, down -115.74% from previous year.
  • TELCON RF PHARMACEUTICAL. Inc. reported a quarterly EBITDA of 63.86 Million KRW for 2024 Q2, up 101.03% from previous quarter.
  • TELCON RF PHARMACEUTICAL. Inc. reported a quarterly EBITDA of 521.01 Million KRW for 2023 Q2, up 151.64% from previous quarter.

Annual EBITDA Chart of TELCON RF PHARMACEUTICAL. Inc. (2023 - 2012)

Historical Annual EBITDA of TELCON RF PHARMACEUTICAL. Inc. (2023 - 2012)

Year EBITDA EBITDA Growth
2023 5.2 Billion KRW 2284.56%
2022 -36.77 Billion KRW 160.17%
2021 -363.07 Million KRW -115.74%
2020 -30.72 Billion KRW -69.28%
2019 -33.41 Billion KRW 242.44%
2018 -5.93 Billion KRW 50.86%
2017 -14.89 Billion KRW -48.52%
2016 -3.65 Billion KRW -2925.23%
2015 255.69 Million KRW -96.99%
2014 8.49 Billion KRW -15.75%
2013 10.08 Billion KRW 74.24%
2012 5.78 Billion KRW 0.0%

Peer EBITDA Comparison of TELCON RF PHARMACEUTICAL. Inc.

Name EBITDA EBITDA Difference
Taihan Fiber Optics Co., Ltd -14.71 Billion KRW 135.398%
Kmw Inc. -35.76 Billion KRW 114.565%
Samji Electronics Co., Ltd. 81.82 Billion KRW 93.633%
Intops Co., Ltd. 36.82 Billion KRW 85.853%
Ace Technologies Corp. -59.72 Billion KRW 108.723%
EM-Tech.CO., LTD. 15.45 Billion KRW 66.285%
Humax Co., Ltd. -1.16 Billion KRW 547.229%
Seojin System Co.,Ltd 125.07 Billion KRW 95.835%
RFHIC Corporation 7.91 Billion KRW 34.161%
HFR, Inc. -1.85 Billion KRW 380.92%